Rankings
▼
Calendar
REVB Q1 2020 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
REVB
Revelation Biosciences, Inc.
$2M
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7,160
Net Income
-$7,160
EPS (Diluted)
$-43.51
QoQ Revenue Growth
NaN%
← FY 2020
All Quarters
Q2 2020 →